Dahu Health Industry Co., Ltd. (SHA:600257)
China · Delayed Price · Currency is CNY 4.770
-0.050 (-1.04%)
Jun 18, 2026, 3:00 PM CST
Dahu Health Industry Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.57 | 5.07 | -76.95 | -8.16 | -71.5 | -180.12 |
Depreciation & Amortization | 61.01 | 61.01 | 62.64 | 62.62 | 62.3 | 53.69 |
Other Amortization | 28.05 | 28.05 | 26.65 | 28.02 | 24.18 | 19.85 |
Loss (Gain) From Sale of Assets | -0.57 | -0.57 | -2.28 | -6.44 | -0.41 | 63.36 |
Asset Writedown & Restructuring Costs | 2.36 | 2.36 | 27.66 | 4.65 | 37.27 | 126.61 |
Loss (Gain) From Sale of Investments | -7.55 | -7.55 | 3.72 | 2.65 | 6.97 | -3.27 |
Provision & Write-off of Bad Debts | -2.11 | -2.11 | 6.41 | 6.28 | 20.22 | 5.34 |
Other Operating Activities | 35.9 | 58.33 | 58.13 | 66.48 | 41.89 | 71.69 |
Change in Accounts Receivable | 45.3 | 45.3 | -34.88 | 0.89 | 40.64 | -13.44 |
Change in Inventory | 27.37 | 27.37 | 9.2 | 65.81 | -34.82 | 39.59 |
Change in Accounts Payable | -1.07 | -1.07 | -29.94 | -51.12 | -20.46 | -80.08 |
Operating Cash Flow | 196.05 | 217.99 | 67.45 | 162.09 | 97.87 | 96.42 |
Operating Cash Flow Growth | 46.69% | 223.18% | -58.39% | 65.62% | 1.50% | - |
Capital Expenditures | -42.12 | -9.7 | -21.34 | -19.2 | -61.81 | -79.69 |
Sale of Property, Plant & Equipment | 0.1 | 0.27 | 7.15 | 9.37 | 0.73 | 0.95 |
Cash Acquisitions | -22.93 | - | - | - | -15 | - |
Divestitures | - | - | 0.17 | 7.58 | 0 | - |
Investment in Securities | -23.05 | -3.48 | -13.57 | 12.08 | 12.19 | -31.76 |
Other Investing Activities | 41.26 | 6.3 | 0.46 | - | 0.62 | 2.72 |
Investing Cash Flow | -46.74 | -6.62 | -27.13 | 9.83 | -63.27 | -107.78 |
Long-Term Debt Issued | - | 273 | 210 | 322.2 | 335.2 | 535.4 |
Long-Term Debt Repaid | - | -337.76 | -382.8 | -370.43 | -446.91 | -375.5 |
Net Debt Issued (Repaid) | -86.77 | -64.76 | -172.8 | -48.23 | -111.71 | 159.9 |
Common Dividends Paid | -10.84 | -11.71 | -15.85 | -18.98 | -21.15 | -38.41 |
Other Financing Activities | -7.49 | -4.35 | -0.75 | 0.44 | -0.06 | -0.08 |
Financing Cash Flow | -105.1 | -80.81 | -189.4 | -66.77 | -132.93 | 121.41 |
Net Cash Flow | 44.21 | 130.56 | -149.08 | 105.15 | -98.34 | 110.05 |
Free Cash Flow | 153.93 | 208.28 | 46.12 | 142.89 | 36.05 | 16.73 |
Free Cash Flow Growth | 31.37% | 351.65% | -67.73% | 296.30% | 115.48% | - |
Free Cash Flow Margin | 16.76% | 22.64% | 4.42% | 11.97% | 3.29% | 1.29% |
Free Cash Flow Per Share | 0.30 | 0.41 | 0.10 | 0.35 | 0.08 | 0.03 |
Cash Income Tax Paid | 59.83 | 63.98 | 68.89 | 87.59 | 68.34 | 58.7 |
Levered Free Cash Flow | 76.89 | 181.2 | 40.25 | 133.14 | -23.76 | 59.04 |
Unlevered Free Cash Flow | 97.4 | 202.24 | 63.32 | 159.15 | 3.62 | 85.32 |
Change in Working Capital | 73.4 | 73.4 | -38.53 | 6 | -23.06 | -60.72 |